{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:20:08Z","timestamp":1793215208882,"version":"4.5.0"},"reference-count":112,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"vor","delay-in-days":4113,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1111\/j.1538-7836.2011.04429.x","type":"journal-article","created":{"date-parts":[[2011,7,5]],"date-time":"2011-07-05T17:21:28Z","timestamp":1309886488000},"page":"1713-1723","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":238,"title":["Hypercoagulability in cirrhosis: causes and consequences"],"prefix":"10.1016","volume":"9","author":[{"given":"A.","family":"TRIPODI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.M.","family":"ANSTEE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.K.","family":"SOGAARD","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"PRIMIGNANI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.C.","family":"VALLA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0010","series-title":"Chronic Liver Failure: Mechanisms and Management","first-page":"289","article-title":"Hemostasis abnormalities in chronic liver failure","author":"Tripodi","year":"2010"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0015","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/MOH.0b013e32830a9746","article-title":"Thrombocytopenia in liver disease","volume":"15","author":"Giannini","year":"2008","journal-title":"Curr Opin Hematol"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0020","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/hep.20569","article-title":"Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests","volume":"41","author":"Tripodi","year":"2005","journal-title":"Hepatology"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0025","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/hep.21266","article-title":"Thrombin generation in patients with cirrhosis: the role of platelets","volume":"44","author":"Tripodi","year":"2006","journal-title":"Hepatology"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0030","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jhep.2009.12.001","article-title":"Normal to increased thrombin generation in patients undergoing liver transplantation despite prolonged conventional coagulation tests","volume":"52","author":"Lisman","year":"2010","journal-title":"J Hepatol"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0035","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1111\/j.1538-7836.2010.03937.x","article-title":"Enhanced thrombin generation in patients with cirrhosis\u2010induced coagulopathy","volume":"8","author":"Gatt","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0040","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2141.2009.07833.x","article-title":"Acquired coagulation disorders: revisited using global coagulation\/anticoagulation testing","volume":"147","author":"Tripodi","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0045","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1053\/j.gastro.2004.07.015","article-title":"Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double\u2010blind trial","volume":"127","author":"Bosch","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0050","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1002\/hep.22216","article-title":"Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: a randomized, controlled trial","volume":"47","author":"Bosch","year":"2008","journal-title":"Hepatology"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0055","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/lt.20470","article-title":"Efficacy and safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation","volume":"11","author":"Lodge","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0060","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/lt.20458","article-title":"Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation due to chronic liver disease","volume":"11","author":"Planinsic","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0065","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/hep.21303","article-title":"Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management","volume":"44","author":"Caldwell","year":"2006","journal-title":"Hepatology"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0070","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep.21231","article-title":"Elevated levels of von Willebrand factor in cirrhosis support platelet adhesion despite reduced functional capacity","volume":"44","author":"Lisman","year":"2006","journal-title":"Hepatology"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0075","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1053\/gast.2001.25481","article-title":"Thrombin\u2010activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis","volume":"121","author":"Lisman","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0080","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1053\/jhep.2003.50277","article-title":"Deficiency of thrombin activatable fibrinolysis inhibitor in cirrhosis is associated with increased plasma fibrinolysis","volume":"38","author":"Colucci","year":"2003","journal-title":"Hepatology"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0085","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1053\/j.gastro.2009.08.045","article-title":"An imbalance of pro\u2010 vs anti\u2010coagulation factors in plasma from patients with cirrhosis","volume":"137","author":"Tripodi","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0090","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1532\/IJH97.03149","article-title":"Progress in the understanding of the protein C anticoagulant pathway","volume":"79","author":"Dahlback","year":"2004","journal-title":"Int J Hematol"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0095","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/hep.23653","article-title":"Detection of the imbalance of pro\u2010 vs. anti\u2010coagulant factors in cirrhosis by a simple laboratory method","volume":"52","author":"Tripodi","year":"2010","journal-title":"Hepatology"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0100","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1046\/j.1365-2141.2001.03146.x","article-title":"Marked elevation of thrombin generation in patients with elevated FVIII:C and venous thromboembolism","volume":"115","author":"O\u2019Donnell","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0105","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(05)71880-8","article-title":"Deep vein thrombosis","volume":"365","author":"Kyrle","year":"2005","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0110","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0140-6736(04)16004-2","article-title":"Pulmonary embolism","volume":"363","author":"Goldhaber","year":"2004","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0115","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11239-006-5572-y","article-title":"The epidemiology of venous thromboembolism in the community: implications for prevention and management","volume":"21","author":"Heit","year":"2006","journal-title":"J Thromb Thrombolysis"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0120","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/sj.bjc.6605883","article-title":"Hospitalisation for venous thromboembolism in cancer patients and the general population: a population\u2010based cohort study in Denmark, 1997\u20132006","volume":"103","author":"Cronin\u2010Fenton","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0125","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/archinte.160.6.809","article-title":"Risk factors for deep vein thrombosis and pulmonary embolism: a population\u2010based case\u2013control study","volume":"160","author":"Heit","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0130","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1001\/archinte.167.9.935","article-title":"Risk factors and short\u2010term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom","volume":"167","author":"Huerta","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0135","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1111\/j.1572-0241.2006.00588.x","article-title":"Coagulopathy does not fully protect hospitalized cirrhosis patients from peripheral venous thromboembolism","volume":"101","author":"Northup","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0140","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1007\/s10620-008-0265-3","article-title":"Deep vein thrombosis and pulmonary embolism in cirrhosis patients","volume":"53","author":"Gulley","year":"2008","journal-title":"Dig Dis Sci"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0145","first-page":"259","article-title":"Venous thromboembolism and liver cirrhosis","volume":"100","author":"Garcia\u2010Fuster","year":"2008","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0150","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1378\/chest.09-2177","article-title":"Coagulopathy does not protect against venous thromboembolism in hospitalized patients with chronic liver disease","volume":"137","author":"Dabbagh","year":"2010","journal-title":"Chest"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0155","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/MBC.0b013e328337b3ba","article-title":"Venous thrombosis in patients with chronic liver disease","volume":"21","author":"Lizarraga","year":"2010","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0160","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.cgh.2010.05.014","article-title":"Liver cirrhosis is associated with venous thromboembolism among hospitalized patients in a nationwide US study","volume":"8","author":"Wu","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0165","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.amjmed.2010.08.014","article-title":"Venous thromboembolism with chronic liver disease","volume":"124","author":"Saleh","year":"2011","journal-title":"Am J Med"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-9560-9-1","article-title":"The incidence of venous thromboembolism and practice of deep venous thrombosis prophylaxis in hospitalized cirrhotic patients","volume":"9","author":"Aldawood","year":"2011","journal-title":"Thromb J"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0175","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1007\/s10620-011-1582-5","article-title":"Deep venous thrombosis and pulmonary embolism in hospitalized patients with cirrhosis: a nationwide analysis","volume":"56","author":"Ali","year":"2011","journal-title":"Dig Dis Sci"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0180","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/ajg.2008.34","article-title":"Risk of venous thromboembolism in patients with liver disease: a nationwide population\u2010based case\u2013control study","volume":"104","author":"S\u00f8gaard","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0185","doi-asserted-by":"crossref","first-page":"6119","DOI":"10.3748\/wjg.v16.i48.6119","article-title":"High prevalence of nonalcoholic fatty liver in patients with idiopathic venous thromboembolism","volume":"16","author":"Di Minno","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0190","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/hep.510270224","article-title":"Pathology of the liver in Budd\u2010Chiari syndrome: portal vein thrombosis and the histogenesis of veno\u2010centric cirrhosis, veno\u2010portal cirrhosis, and large regenerative nodules","volume":"27","author":"Tanaka","year":"1998","journal-title":"Hepatology"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0195","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1136\/gut.52.8.1206","article-title":"Factor V Leiden polymorphism and the rate of fibrosis development in chronic hepatitis C virus infection","volume":"52","author":"Wright","year":"2003","journal-title":"Gut"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0200","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/hep.20166","article-title":"Factor V Leiden as a risk factor for cirrhosis in chronic hepatitis C","volume":"39","author":"Poujol\u2010Robert","year":"2004","journal-title":"Hepatology"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0205","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1572-0241.2004.04092.x","article-title":"Genetic and acquired thrombotic factors in chronic hepatitis C","volume":"99","author":"Poujol\u2010Robert","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0210","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1111\/j.1538-7836.2008.03015.x","article-title":"Coagulation status modulates murine hepatic fibrogenesis: implications for the development of novel therapies","volume":"6","author":"Anstee","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0215","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1055\/s-0037-1615623","article-title":"Pulmonary fibrosis is increased in mice carrying the factor V Leiden mutation following bleomycin injury","volume":"85","author":"Xu","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0220","first-page":"1232","article-title":"Role of thrombosis in the pathogenesis of congestive hepatic fibrosis (cardiac cirrhosis)","volume":"21","author":"Wanless","year":"1995","journal-title":"Hepatology"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0225","first-page":"1238","article-title":"Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension","volume":"21","author":"Wanless","year":"1995","journal-title":"Hepatology"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0230","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cld.2008.09.013","article-title":"Parenchymal extinction: coagulation and hepatic fibrogenesis","volume":"13","author":"Anstee","year":"2009","journal-title":"Clin Liver Dis"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0235","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.addr.2009.03.011","article-title":"Transcriptional regulation of hepatic stellate cells","volume":"61","author":"Mann","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0240","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jhep.2010.02.005","article-title":"Fibrogenic signalling in hepatic stellate cells","volume":"52","author":"Mann","year":"2010","journal-title":"J Hepatol"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0245","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/hep.20054","article-title":"PAR1 antagonism protects against experimental liver fibrosis. Role of proteinase receptors in stellate cell activation","volume":"39","author":"Fiorucci","year":"2004","journal-title":"Hepatology"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0250","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/hep.510270221","article-title":"Expression of the thrombin receptor in human liver: up\u2010regulation during acute and chronic injury","volume":"27","author":"Marra","year":"1998","journal-title":"Hepatology"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0255","doi-asserted-by":"crossref","first-page":"11S","DOI":"10.1378\/chest.124.3_suppl.11S","article-title":"Thrombin interactions","volume":"124","author":"Di Cera","year":"2003","journal-title":"Chest"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0260","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2353\/ajpath.2008.070347","article-title":"Factor Xa stimulates proinflammatory and profibrotic responses in fibroblasts via protease\u2010activated receptor\u20102 activation","volume":"172","author":"Borensztajn","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0265","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1182\/blood.V97.10.3109","article-title":"Gene induction by coagulation factor Xa is mediated by activation of protease\u2010activated receptor 1","volume":"97","author":"Riewald","year":"2001","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0270","doi-asserted-by":"crossref","first-page":"7742","DOI":"10.1073\/pnas.141126698","article-title":"Mechanistic coupling of protease signaling and initiation of coagulation by tissue factor","volume":"98","author":"Riewald","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0275","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1172\/JCI27183","article-title":"Ligation of protease\u2010activated receptor 1 enhances alpha(v)beta6 integrin\u2010dependent TGF\u2010beta activation and promotes acute lung injury","volume":"116","author":"Jenkins","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0280","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0168-8278(01)00285-9","article-title":"Regulation of hepatic stellate cell proliferation and collagen synthesis by proteinase\u2010activated receptors","volume":"36","author":"Gaca","year":"2002","journal-title":"J Hepatol"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0285","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.2353\/ajpath.2010.100425","article-title":"The coagulation system contributes to alphaVbeta6 integrin expression and liver fibrosis induced by cholestasis","volume":"177","author":"Sullivan","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0290","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0002-9440(10)62354-1","article-title":"Absence of proteinase\u2010activated receptor\u20101 signaling affords protection from bleomycin\u2010induced lung inflammation and fibrosis","volume":"166","author":"Howell","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0295","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1111\/j.1440-1746.2007.05220.x","article-title":"Effect of a thrombin receptor (protease\u2010activated receptor 1, PAR\u20101) gene polymorphism in chronic hepatitis C liver fibrosis","volume":"23","author":"Martinelli","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0300","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1203\/01.PDR.0000161416.63314.70","article-title":"High expression of pulmonary proteinase\u2010activated receptor 2 in acute and chronic lung injury in preterm infants","volume":"57","author":"Cederqvist","year":"2005","journal-title":"Pediatr Res"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0305","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1124\/jpet.104.076232","article-title":"Protease\u2010activated receptor\u20102\u2010mediated proliferation and collagen production of rat pancreatic stellate cells","volume":"312","author":"Masamune","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0310","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/BF02896006","article-title":"Role of protease activated receptor\u20102 expression in renal interstitial fibrosis model in mice","volume":"25","author":"Xiong","year":"2005","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0315","first-page":"2550","article-title":"Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury","volume":"119","author":"Scotton","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0320","doi-asserted-by":"crossref","first-page":"d1720","DOI":"10.2741\/pinzani","article-title":"PDGF and signal transduction in hepatic stellate cells","volume":"7","author":"Pinzani","year":"2002","journal-title":"Front Biosci"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0325","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1053\/j.gastro.2010.02.054","article-title":"Thrombocytopenia exacerbates cholestasis\u2010induced liver fibrosis in mice","volume":"138","author":"Kodama","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0330","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.phrs.2004.04.009","article-title":"A study of unfractionated and low molecular weight heparins in a model of cholestatic liver injury in the rat","volume":"51","author":"Abdel\u2010Salam","year":"2005","journal-title":"Pharmacol Res"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0335","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jhep.2006.08.023","article-title":"Low molecular weight heparin prevents hepatic fibrogenesis caused by carbon tetrachloride in the rat","volume":"46","author":"Abe","year":"2007","journal-title":"J Hepatol"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0340","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1136\/gut.2003.032136","article-title":"A role for thrombin in liver fibrosis","volume":"53","author":"Duplantier","year":"2004","journal-title":"Gut"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0345","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/hep.510240417","article-title":"Hepatic sinusoidal fibrosis induced by cholesterol and stilbestrol in the rabbit: 1. Morphology and inhibition of fibrogenesis by dipyridamole","volume":"24","author":"Wanless","year":"1996","journal-title":"Hepatology"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0350","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1164\/rccm.2201082","article-title":"Prevention of bleomycin\u2010induced lung fibrosis by aerosolization of heparin or urokinase in rabbits","volume":"168","author":"Gunther","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl. 1","key":"10.1111\/j.1538-7836.2011.04429.x_bb0355","first-page":"1125A","article-title":"Factor Xa Inhibition Suppresses Thioacetamide Induced Liver Fibrosis","volume":"52","author":"Dhar","year":"2010","journal-title":"Hepatology"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0360","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.3748\/wjg.v9.i7.1611","article-title":"Effects of heparin on liver fibrosis in patients with chronic hepatitis B","volume":"9","author":"Shi","year":"2003","journal-title":"World J Gastroenterol"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0365","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1378\/chest.128.3.1475","article-title":"Anticoagulant therapy for idiopathic pulmonary fibrosis","volume":"128","author":"Kubo","year":"2005","journal-title":"Chest"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0370","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/gut.47.6.845","article-title":"The natural history of HCV in a cohort of haemophilic patients infected between 1961 and 1985","volume":"47","author":"Yee","year":"2000","journal-title":"Gut"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0375","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1136\/gut.52.3.404","article-title":"Thrombotic risk factors and extent of liver fibrosis in chronic viral hepatitis","volume":"52","author":"Papatheodoridis","year":"2003","journal-title":"Gut"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0380","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1365-2893.2006.00790.x","article-title":"The impact of inherited prothrombotic risk factors on individuals chronically infected with hepatitis C virus from a single source","volume":"14","author":"Goulding","year":"2007","journal-title":"J Viral Hepat"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0385","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jhep.2009.06.023","article-title":"Thrombotic risk factors and liver histologic lesions in non\u2010alcoholic fatty liver disease","volume":"51","author":"Papatheodoridis","year":"2009","journal-title":"J Hepatol"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0390","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1002\/art.30255","article-title":"Anti\u2010inflammatory and anti\u2010fibrotic effects of the oral direct thrombin inhibitor dabigatran etexilate in a murine model of interstitial lung disease","volume":"63","author":"Bogatkevich","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0395","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/hep.1840160515","article-title":"The incidence of portal vein thrombosis at liver transplantation","volume":"16","author":"Nonami","year":"1992","journal-title":"Hepatology"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0400","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.1016\/j.transproceed.2005.10.085","article-title":"Comparative analysis of the results of orthotopic liver transplantation in patients with and without portal vein thrombosis","volume":"37","author":"Gimeno","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0405","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/lt.21941","article-title":"Portal vein thrombosis and survival in patients with cirrhosis","volume":"16","author":"Englesbe","year":"2010","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0410","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1097\/00007890-200005150-00023","article-title":"Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome","volume":"69","author":"Yerdel","year":"2000","journal-title":"Transplantation"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0415","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1091-255X(97)80099-6","article-title":"Portal vein thrombosis in cirrhosis with variceal hemorrhage","volume":"1","author":"Orloff","year":"1997","journal-title":"J Gastrointest Surg"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0420","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1053\/jhep.2003.50385","article-title":"Upper digestive bleeding in cirrhosis. Post\u2010therapeutic outcome and prognostic indicators","volume":"38","author":"D\u2019Amico","year":"2003","journal-title":"Hepatology"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0425","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0016-5085(85)90327-0","article-title":"Incidence of portal vein thrombosis in liver cirrhosis. An angiographic study in 708 patients","volume":"89","author":"Okuda","year":"1985","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0430","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/gut.2004.042796","article-title":"Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation","volume":"54","author":"Francoz","year":"2005","journal-title":"Gut"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0435","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1055\/s-2002-33210","article-title":"Portal vein thrombosis after variceal endoscopic sclerotherapy in cirrhotic patients: role of genetic thrombophilia","volume":"34","author":"Amitrano","year":"2002","journal-title":"Endoscopy"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0440","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/path.1700890204","article-title":"Thrombosis and Intimal Thickening in the Portal System in Cirrhosis of the Liver","volume":"89","author":"Hou","year":"1965","journal-title":"J Pathol Bacteriol"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0445","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0016-5085(86)90973-X","article-title":"Cirrhosis and portal vein thrombosis","volume":"90","author":"Monarca","year":"1986","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0450","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/lt.22105","article-title":"Portal vein thrombosis and liver transplant survival benefit","volume":"16","author":"Englesbe","year":"2010","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0455","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/hep.510290415","article-title":"Preoperative portal vein embolization: an audit of 84 patients","volume":"29","author":"Imamura","year":"1999","journal-title":"Hepatology"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0460","first-page":"1162","article-title":"Fate of the human liver after hemihepatic portal vein embolization: cell kinetic and morphometric study","volume":"26","author":"Harada","year":"1997","journal-title":"Hepatology"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0465","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1399-0012.2009.00977.x","article-title":"Pre\u2010existent portal vein thrombosis in liver transplantation: influence of pre\u2010operative disease severity","volume":"24","author":"Doenecke","year":"2010","journal-title":"Clin Transplant"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0470","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jhep.2004.01.001","article-title":"Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis","volume":"40","author":"Amitrano","year":"2004","journal-title":"J Hepatol"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0475","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/00042737-200507000-00009","article-title":"Causes of portal venous thrombosis in cirrhotic patients: the role of genetic and acquired factors","volume":"17","author":"Mangia","year":"2005","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0480","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.jhep.2009.03.013","article-title":"Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development","volume":"51","author":"Zocco","year":"2009","journal-title":"J Hepatol"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0485","doi-asserted-by":"crossref","DOI":"10.1177\/1076029610369797","article-title":"Antiphospholipid Antibodies and Antiphospholipid Syndrome: role in Portal Vein Thrombosis in Patients With and Without Liver Cirrhosis","author":"Amitrano","year":"2011","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0490","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1016\/S0168-8278(11)60182-7","article-title":"Clinical and genetic factors associated to the development of portal vein thrombosis in cirrhotic patients without hepatocellular carcinoma","volume":"54","author":"Pellicelli","year":"2011","journal-title":"J Hepatol"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0495","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1136\/gut.2007.133637","article-title":"Budd\u2010Chiari syndrome and veno\u2010occlusive disease\/sinusoidal obstruction syndrome","volume":"57","author":"Valla","year":"2008","journal-title":"Gut"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0500","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jhep.2010.06.019","article-title":"Bleeding in patients with Budd\u2010Chiari syndrome","volume":"54","author":"Rautou","year":"2011","journal-title":"J Hepatol"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0505","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/hep.23259","article-title":"Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow\u2010up study","volume":"51","author":"Plessier","year":"2010","journal-title":"Hepatology"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0510","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/hep.22772","article-title":"Vascular disorders of the liver","volume":"49","author":"DeLeve","year":"2009","journal-title":"Hepatology"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0515","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/MCG.0b013e3181b3ab44","article-title":"Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis","volume":"44","author":"Amitrano","year":"2010","journal-title":"J Clin Gastroenterol"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0520","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1016\/S0168-8278(10)60188-2","article-title":"Portal vein thrombosis in cirrhotic patients: safety and efficacy of low dosage of enoxaparin","volume":"52","author":"Pellicelli","year":"2010","journal-title":"J Hepatol"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2011.02.027","article-title":"Tips for Portal Vein Thrombosis (PVT) in Cirrhosis: not Only Unblocking a Pipe","author":"Senzolo","year":"2011","journal-title":"J Hepatol"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0530","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1136\/gut.2010.228023","article-title":"Short\u2010 and long\u2010term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis","volume":"60","author":"Luca","year":"2011","journal-title":"Gut"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0535","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jhep.2010.06.029","article-title":"Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis","volume":"54","author":"Han","year":"2011","journal-title":"J Hepatol"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0540","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00270-005-0090-4","article-title":"Transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis and concomitant portal vein thrombosis","volume":"29","author":"Van Ha","year":"2006","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0545","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1002\/lt.20869","article-title":"The role of TIPS for portal vein patency in liver transplant patients with portal vein thrombosis","volume":"12","author":"Bauer","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0550","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1097\/MEG.0b013e328338d995","article-title":"Feasibility and long\u2010term evolution of TIPS in cirrhotic patients with portal thrombosis","volume":"22","author":"Perarnau","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0555","doi-asserted-by":"crossref","first-page":"S460","DOI":"10.1016\/S0168-8278(10)61187-7","article-title":"Anticoagulant therapy is safe and effective in preventing portal vein thrombosis in advanced cirrhotic patients: a prospective randomized controlled study","volume":"52","author":"Zecchini","year":"2010","journal-title":"J Hepatol"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0560","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1478-3231.2010.02358.x","article-title":"Low\u2010molecular\u2010weight heparin in patients with advanced cirrhosis","volume":"31","author":"Bechmann","year":"2011","journal-title":"Liver Int"},{"key":"10.1111\/j.1538-7836.2011.04429.x_bb0565","series-title":"Quality in Laboratory Hemostasis and Thrombosis","first-page":"179","article-title":"Monitoring oral anticoagulant therapy","author":"Tripodi","year":"2009"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2011.04429.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622071252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622071252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2011.04429.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:57:42Z","timestamp":1761533862000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622071252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":112,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S1538783622071252"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2011.04429.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypercoagulability in cirrhosis: causes and consequences","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2011.04429.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}